TY - JOUR
T1 - Correction to
T2 - Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members (Annals of Surgical Oncology, (2019), 26, 10, (3321-3336), 10.1245/s10434-019-07547-w)
AU - Landercasper, Jeffrey
AU - Borgert, Andrew J.
AU - Fayanju, Oluwadamilola M.
AU - Cody, Hiram
AU - Feldman, Sheldon
AU - Greenberg, Caprice
AU - Linebarger, Jared
AU - Pockaj, Barbara
AU - Wilke, Lee
N1 - Funding Information:
Andrew Borgert and Dr. Landercasper received funding from the Gundersen Medical Foundation; however, this is unrelated to the content of this manuscript. Dr. Fayanju was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Number 1KL2TR002554 (PI: Svetkey) and by the Duke Cancer Institute through NIH grant P30CA014236 (PI: Kastan). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Cody, Dr. Feldman, Dr. Linebarger, and Dr. Pockaj have no disclosures. Dr. Greenberg is a consultant for Johnson and Johnson on their Global Education Council; this is unrelated to the content of this manuscript. Dr. Wilke is a founder and minority stock owner in Elucent Medical; this is unrelated to the content of this manuscript. Dr. Wilke also served in the following roles: site PI (non-compensated) for a clinical trial evaluating an optical breast tumor margin assessment device (Perimeter Medical Imaging), co-I (partial compensation) of an NIH/NIBIB R01 (R01EB020521)-funded clinical trial evaluating breast tissue imaging of mastectomy specimens, and site PI (partial compensation) of an optical intraoperative breast tumor margin assessment device through a subcontract from Duke University, NIH R01 (EB011574).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The Disclosures in the original article are incomplete. Not included is the following information: Dr. Wilke also served in the following roles: site PI (non-compensated) for a clinical trial evaluating an optical breast tumor margin assessment device (Perimeter Medical Imaging), co-I (partial compensation) of an NIH/NIBIB R01 (R01EB020521)-funded clinical trial evaluating breast tissue imaging of mastectomy specimens, and site PI (partial compensation) of an optical intraoperative breast tumor margin assessment device through a subcontract from Duke University, NIH R01 (EB011574).
AB - The Disclosures in the original article are incomplete. Not included is the following information: Dr. Wilke also served in the following roles: site PI (non-compensated) for a clinical trial evaluating an optical breast tumor margin assessment device (Perimeter Medical Imaging), co-I (partial compensation) of an NIH/NIBIB R01 (R01EB020521)-funded clinical trial evaluating breast tissue imaging of mastectomy specimens, and site PI (partial compensation) of an optical intraoperative breast tumor margin assessment device through a subcontract from Duke University, NIH R01 (EB011574).
UR - http://www.scopus.com/inward/record.url?scp=85073784686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073784686&partnerID=8YFLogxK
U2 - 10.1245/s10434-019-07799-6
DO - 10.1245/s10434-019-07799-6
M3 - Comment/debate
C2 - 31512023
AN - SCOPUS:85073784686
SN - 1068-9265
VL - 26
SP - 891
JO - Annals of surgical oncology
JF - Annals of surgical oncology
ER -
